(NASDAQ: FRMM) Forum Markets's forecast annual revenue growth rate of 99.24% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 46.89%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.94%.
Forum Markets's revenue in 2026 is $10,771,000.On average, 5 Wall Street analysts forecast FRMM's revenue for 2026 to be $249,394,122, with the lowest FRMM revenue forecast at $235,073,264, and the highest FRMM revenue forecast at $263,319,013. On average, 5 Wall Street analysts forecast FRMM's revenue for 2027 to be $580,951,696, with the lowest FRMM revenue forecast at $454,756,554, and the highest FRMM revenue forecast at $672,156,427.
In 2028, FRMM is forecast to generate $860,663,802 in revenue, with the lowest revenue forecast at $660,409,363 and the highest revenue forecast at $1,064,363,167.